文献速递肺外科

Medicare受益者肺癌切除术的医院间费用差异

Hospital Variation in Spending for Lung Cancer Resection in Medicare Beneficiaries.
PubMed 文献 · Ann Thorac Surg · 2019-08-07

该研究基于SEER-Medicare数据库,分析2006至2011年3530例I期非小细胞肺癌患者在156家医院行肺叶切除术后的90天费用。医院按平均超额费用五分位分组,最低费用组指数住院费用比预测低6226美元,最高费用组比预测高6151美元。费用增加与每例患者并发症数量正相关(P < .001),但与医院体量无关(P = .85)。

要点

  • I期NSCLC肺叶切除术后90天费用在医院间差异显著。
  • 并发症数量与费用增加正相关(P < .001)。
  • 医院体量与费用无显著关联(P = .85)。

核心结论

  • Medicare受益者I期NSCLC肺叶切除术后围手术期费用在医院间差异大,且与并发症率强相关,与医院体量无关。

研究设计与样本

  • 回顾性队列研究,从SEER-Medicare linked数据库选取2006至2011年诊断为I期NSCLC并行肺叶切除术的患者,共3530例,分布于156家医院。

主要发现

  • 最低费用五分位医院指数住院费用比预测低6226美元,最高费用五分位医院比预测高6151美元。
  • 费用增加与每例患者并发症数量正相关(P < .001)。
  • 费用与医院体量无显著关联(P = .85)。

关键数值与推荐

  • 医院按平均超额费用五分位分组,超额费用为观察费用与风险调整预测费用之差。
  • 费用估计为初始手术住院后90天内的医疗费用。

临床怎么用

  • 在肺癌切除术费用管控中应关注并发症预防而非医院体量。
  • 医院间费用差异提示需针对高费用医院优化围手术期管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: As cancer payment models transition from fee for service toward payment "bundles" based on episodes of care, a deeper understanding of the costs associated with stage I lung cancer treatment becomes increasingly relevant. To better understand costs in early lung cancer care, we sought to characterize hospital-level variation in Medicare expenditure after lobectomy for stage I non-small cell lung carcinoma. METHODS: Patients who were diagnosed with stage I non-small cell lung carcinoma from 2006 through 2011 and undergoing lobectomy were selected from the Surveillance, Epidemiology and End Results-Medicare linked database. We used Medicare claims to estimate costs of care in the 90 days after initial surgical hospitalization. Hospitals were grouped into quintiles of mean excess cost, calculated as the mean difference between observed costs and risk-adjusted predicted costs. The association between hospital factors and mean excess cost were compared across hospitals, including complication rates and hospital volume. RESULTS: A total of 3530 patients underwent lobectomy at 156 hospitals. Hospitals in the lowest cost quintile had index hospitalizations $6226 less costly than predicted. Conversely, the most expensive hospital quintile had index hospital costs that were $6151 costlier than predicted. Increased costs were positively associated with the number of complications per patient (P < .001), but not hospital volume (P = .85). CONCLUSIONS: Among Medicare beneficiaries undergoing lobectomy for stage I non-small cell lung carcinoma, the cost of perioperative care varied substantially across hospitals and was strongly associated with complication rate, but not hospital volume.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Jean RA, Bongiovanni T, Soulos PR, et al. Hospital Variation in Spending for Lung Cancer Resection in Medicare Beneficiaries. Ann Thorac Surg. 2019. PMID: 31400321. doi:10.1016/j.athoracsur.2019.06.048

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。